TP53 stimulates PLK2 expression

Stable Identifier
R-HSA-6801637
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Binding of TP53 to p53 binding site(s) in the promoter of the PLK2 gene stimulates PLK2 transcription. PLK2 may be involved in prevention of the mitotic catastrophe after spindle damage (Burns et al. 2003). PLK2 is frequently transcriptionally silenced through promoter methylation in B-cell malignancies (Syed et al. 2006).

Literature References
PubMed ID Title Journal Year
12897130 Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells

Burns, TF, Fei, P, Scata, KA, Dicker, DT, El-Deiry, WS

Mol. Cell. Biol. 2003
16160013 Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies

Syed, N, Smith, P, Sullivan, A, Spender, LC, Dyer, M, Karran, L, O'Nions, J, Allday, M, Hoffmann, I, Crawford, D, Griffin, B, Farrell, PJ, Crook, T

Blood 2006
Participants
Participant Of
This event is regulated
Authored
Reviewed
Created